Qiagen NV (QGEN)
42.78
+0.45
(+1.06%)
USD |
NYSE |
Nov 22, 16:00
42.79
+0.01
(+0.02%)
Pre-Market: 20:00
Qiagen Price: 42.78 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 42.77 | 42.90 | 42.55 | 42.78 | 679923.0 |
Nov 21, 2024 | 42.22 | 42.48 | 42.04 | 42.33 | 960301.0 |
Nov 20, 2024 | 40.63 | 42.42 | 40.48 | 42.09 | 1.864M |
Nov 19, 2024 | 40.55 | 41.01 | 40.35 | 40.80 | 736441.0 |
Nov 18, 2024 | 40.79 | 41.20 | 40.73 | 40.99 | 1.091M |
Nov 15, 2024 | 41.97 | 41.97 | 40.97 | 41.27 | 1.234M |
Nov 14, 2024 | 42.85 | 42.86 | 42.03 | 42.09 | 545645.0 |
Nov 13, 2024 | 42.78 | 42.85 | 42.41 | 42.63 | 803279.0 |
Nov 12, 2024 | 43.88 | 43.99 | 43.23 | 43.23 | 933446.0 |
Nov 11, 2024 | 43.79 | 44.09 | 43.54 | 44.05 | 977204.0 |
Nov 08, 2024 | 44.22 | 44.27 | 43.63 | 43.76 | 807301.0 |
Nov 07, 2024 | 45.19 | 45.35 | 43.83 | 44.15 | 1.451M |
Nov 06, 2024 | 43.02 | 44.06 | 42.71 | 43.87 | 1.601M |
Nov 05, 2024 | 43.69 | 44.07 | 43.45 | 43.95 | 869581.0 |
Nov 04, 2024 | 43.56 | 43.86 | 43.45 | 43.65 | 1.257M |
Nov 01, 2024 | 42.88 | 43.22 | 42.73 | 43.08 | 873496.0 |
Oct 31, 2024 | 42.06 | 42.39 | 41.89 | 42.10 | 925569.0 |
Oct 30, 2024 | 42.02 | 42.47 | 41.92 | 42.24 | 928685.0 |
Oct 29, 2024 | 41.66 | 42.04 | 41.58 | 41.83 | 476024.0 |
Oct 28, 2024 | 42.08 | 42.17 | 41.74 | 41.80 | 615925.0 |
Oct 25, 2024 | 41.70 | 42.00 | 41.51 | 41.55 | 492400.0 |
Oct 24, 2024 | 42.23 | 42.29 | 41.58 | 41.60 | 567391.0 |
Oct 23, 2024 | 42.21 | 42.26 | 41.93 | 42.12 | 489589.0 |
Oct 22, 2024 | 42.07 | 42.40 | 41.79 | 42.21 | 759736.0 |
Oct 21, 2024 | 42.64 | 42.65 | 41.87 | 42.12 | 588995.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
33.93
Minimum
Dec 26 2019
58.59
Maximum
Sep 02 2021
47.39
Average
47.25
Median
Mar 23 2023
Price Benchmarks
LENZ Therapeutics Inc | 35.50 |
Oruka Therapeutics Inc | 20.75 |
Boston Scientific Corp | 90.00 |
Merus NV | 45.49 |
uniQure NV | 5.78 |
Price Related Metrics
PE Ratio | 105.21 |
PS Ratio | 4.763 |
Price to Book Value | 2.694 |
Price to Free Cash Flow | 20.38 |
Earnings Yield | 0.95% |
Market Cap | 9.508B |
Operating PE Ratio | 51.96 |
Normalized PE Ratio | 57.29 |